Your browser doesn't support javascript.
loading
Ocular Side Effects of EGFR-Inhibitor ABT-414 in Recurrent Glioblastoma: A Long-Term Safety Study.
Parrozzani, Raffaele; Lombardi, Giuseppe; Midena, Edoardo; Londei, Davide; Padovan, Marta; Marchione, Giulia; Caccese, Mario; Midena, Giulia; Zagonel, Vittorina; Frizziero, Luisa.
Afiliación
  • Parrozzani R; Department of Ophthalmology, University of Padova, Padova, Italy.
  • Lombardi G; Department of Oncology, Oncology 1, Veneto Institute of Oncology-IRCCS, Padua, Italy.
  • Midena E; Department of Ophthalmology, University of Padova, Padova, Italy.
  • Londei D; IRCCS-Fondazione Bietti, Rome, Italy.
  • Padovan M; Department of Ophthalmology, University of Padova, Padova, Italy.
  • Marchione G; Department of Oncology, Oncology 1, Veneto Institute of Oncology-IRCCS, Padua, Italy.
  • Caccese M; Department of Ophthalmology, University of Padova, Padova, Italy.
  • Midena G; Department of Oncology, Oncology 1, Veneto Institute of Oncology-IRCCS, Padua, Italy.
  • Zagonel V; Unità Operativa Complessa Oftalmologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Frizziero L; Department of Oncology, Oncology 1, Veneto Institute of Oncology-IRCCS, Padua, Italy.
Front Oncol ; 10: 593461, 2020.
Article en En | MEDLINE | ID: mdl-33154952
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2020 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2020 Tipo del documento: Article País de afiliación: Italia